SCHEMBL5544335

SCHEMBL5544335

CC(C)(C)C(=O)NCCC(N)=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.42
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA7 P43166 1/20 0.36
CA14 Q9ULX7 1/20 0.36
KDM4E B2RXH2 3/20 0.35
MAPT P10636 1/20 0.35
ECE1 P42892 1/20 0.34
TP53 P04637 1/20 0.34
ALDH1A1 P00352 3/20 0.33
DRD4 P21917 3/20 0.33
DRD2 P14416 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2746099 0.84 ECE1 (0.33) POLBECE1ALDH1A1SMN1; SMN2MAOA
SCHEMBL16316312 0.80 POLB (0.50) POLBCA1CA2CA7CA14
SCHEMBL2861129 0.79 POLB (0.47) POLBKDM4EECE1DRD4DRD2
SCHEMBL684805 0.79 POLB (0.43) POLBCA1CA2CA7CA14
SCHEMBL16185833 0.79 POLB (0.43) POLBCA1CA2CA7CA14
SCHEMBL19169704 0.78 CNR1 (0.34) ECE1
SCHEMBL19176795 0.78 DRD2 (0.40) TP53ALDH1A1DRD4DRD2MEN1
SCHEMBL7771469 0.77 ALDH1A1 (0.60) POLBCA2CA7CA14ALDH1A1
SCHEMBL7770037 0.77 LMNA (0.40) POLBECE1ALDH1A1SMN1; SMN2MEN1
SCHEMBL5544499 0.76 MAOA (0.38) POLBCA1CA2CA7CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8178681-B2 methyl 3-methyl-2-{[2-oxo-1-(2-oxo-ethyl)-1,2,5,6,7,8,9,10-octahydro-cycloocta[b]pyridine-3-carbonyl]-amino}-butyrate; cannabinoid receptor agonist; antiinflammatory agent, immunostimulant, analgesic; atopic dermatitis; excellent in photostability, and have excellent transdermal and oral absorbency SHIONOGI & CO., LTD. (JP) 2012-05-15 US disclosed